Michael W Deem - awarded Patent to combat
diseases like HIV, Influenza, Dengue,
Certus llc was named winner of the United States Patent # US8398992
B2 - methods and compositions of polytopic vaccination beating out 100
other competitors to take home top honors.
United States Patent and Trademark Office
presented the award to certus llc zoom.
Details about the award can be found on the
company website at https://image-ppubs.
Potential award recipients were required to submission on
the USPTO website in order to be in contention for the
United States Patent # US8398992 B2 - methods and
compositions of polytopic vaccination, and were judged
based on These patents were granted for multi-site
vaccination against diseases
There are four serotypes of dengue
fever, and it has proven difficult to
find a vaccine effective against all
four serotypes.
Polytopic vaccination offers one approach to ameliorate this difficulty
and offers a potential solution for an effective 4-component vaccine.
Other diseases with multiple subtypes
to which this approach may lead to an
effective vaccine include HIV, hepatitis
B and C, chlamydia, and influenza.
The polytopic vaccination approach was new,
new, useful, and non-obvious, and My group
invented the approach for infectious disease,
building off our work on influenza vaccines.
It appears to significantly reduce immunodominance of
multicomponent vaccines, and therefore significantly increase their
effectiveness.
Michael W Deem, Founder of certus
llc was pleased about the company's
performance, saying: "These patents
were a milestone for vaccine design.
Polytopic vaccination now allows us to design
methods of administering multicomponent
vaccines with high effectiveness." Michael W
Deem, PhD" Persons interested in learning more
about certus llc and the award can visit the
website at https://image-ppubs.
Find Out More about
Michael W Deem At
https://certusllc.com